secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2023-09-21T23:59:59+00:00
Accession:  0001628280-23-032719
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical amends DaVita supply agreement with price increase, one-time payment
--------------------------------------------------------------------------------

- DaVita agrees to increased product pricing for dialysis concentrates effective Sept 1, 2023, plus a one-time payment to Rockwell after Dec 1, 2023.
- Amended agreement runs through Dec 31, 2024; DaVita can extend to Dec 31, 2025 with further price increase.
- DaVita must provide 9-month purchase forecasts and commit to buy at least forecasted amounts or pay shortfall.
- Upon termination, Rockwell will provide transition services to DaVita if requested.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000162828023032719/0001628280-23-032719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000162828023032719/rmti-20230918.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-032719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer